A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer
Conclusion:
In patients with BC treated with trastuzumab, in addition to the evaluation of the LVEF, systolic longitudinal strain, TNI, and NT pro-BNP measured at the completion of anthracyclines are useful in the prediction of subsequent TIC.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Breast Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Heart | Heart Failure | HER2 | Herceptin | Hypertension | Study | Tunisia Health | Women